Trial Outcomes & Findings for A Pilot Participatory Program Evaluation of a Virtual Trauma Support Program for Autistic Adults (NCT NCT05862467)
NCT ID: NCT05862467
Last Updated: 2026-07-02
Results Overview
The Posttraumatic Symptom Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 is a self-report questionnaire of posttraumatic stress disorder symptoms. Total scores range from 0-80; higher scores indicate higher levels of posttraumatic stress disorder symptoms.
COMPLETED
NA
28 participants
Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)
2026-07-02
Participant Flow
Autistic adults were enrolled in this study from October 2023 to July 2024. Participants were recruited through flyers and advertisements posted to social media, listservs, and clinic emails.
Participants were excluded from the study prior to enrollment if they did not meet study inclusion criteria.
Participant milestones
| Measure |
Written Exposure Therapy
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Enrollment to End of Intervention
STARTED
|
28
|
|
Enrollment to End of Intervention
COMPLETED
|
23
|
|
Enrollment to End of Intervention
NOT COMPLETED
|
5
|
|
1 Month Follow Up
STARTED
|
23
|
|
1 Month Follow Up
COMPLETED
|
19
|
|
1 Month Follow Up
NOT COMPLETED
|
4
|
|
6 Month Follow Up
STARTED
|
19
|
|
6 Month Follow Up
COMPLETED
|
18
|
|
6 Month Follow Up
NOT COMPLETED
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Pilot Participatory Program Evaluation of a Virtual Trauma Support Program for Autistic Adults
Baseline characteristics by cohort
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Age, Continuous
|
37.25 Years
STANDARD_DEVIATION 11.60 • n=20 Participants
|
|
Sex/Gender, Customized
Sex/Gender · Female
|
20 Participants
n=20 Participants
|
|
Sex/Gender, Customized
Sex/Gender · Male
|
3 Participants
n=20 Participants
|
|
Sex/Gender, Customized
Sex/Gender · Unknown/Not Reported
|
5 Participants
n=20 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=20 Participants
|
|
Race (NIH/OMB)
White
|
21 Participants
n=20 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=20 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
26 Participants
n=20 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=20 Participants
|
|
Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
|
40.64 Score on scale
STANDARD_DEVIATION 13.54 • n=20 Participants
|
PRIMARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Posttraumatic Symptom Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 is a self-report questionnaire of posttraumatic stress disorder symptoms. Total scores range from 0-80; higher scores indicate higher levels of posttraumatic stress disorder symptoms.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Posttraumatic Stress Disorder (PTSD) Symptoms on the Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
Baseline
|
40.64 Score on a Scale
Standard Deviation 13.54
|
|
Change in Posttraumatic Stress Disorder (PTSD) Symptoms on the Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
End of Intervention
|
22.00 Score on a Scale
Standard Deviation 16.01
|
|
Change in Posttraumatic Stress Disorder (PTSD) Symptoms on the Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
1 Month Follow-Up
|
19.11 Score on a Scale
Standard Deviation 13.73
|
|
Change in Posttraumatic Stress Disorder (PTSD) Symptoms on the Posttraumatic Symptom Checklist for DSM-5 (PCL-5) Scale
6 Month Follow-Up
|
17.82 Score on a Scale
Standard Deviation 15.96
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The PHQ is a self-report measure of depressive symptoms. Total scores range from 0-27; higher scores reflect greater levels of depressive symptoms.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Depressive Symptoms on the Patient Health Questionnaire (PHQ) Scale
Baseline
|
14.25 Score on a Scale
Standard Deviation 4.56
|
|
Change in Depressive Symptoms on the Patient Health Questionnaire (PHQ) Scale
End of Intervention
|
9.83 Score on a Scale
Standard Deviation 5.45
|
|
Change in Depressive Symptoms on the Patient Health Questionnaire (PHQ) Scale
1 Month Follow-Up
|
9.79 Score on a Scale
Standard Deviation 5.37
|
|
Change in Depressive Symptoms on the Patient Health Questionnaire (PHQ) Scale
6 Month Follow-Up
|
9.44 Score on a Scale
Standard Deviation 5.35
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Anxiety Scale for Autism-Adults (ASA-A) is a self-report measure for anxiety symptoms among autistic adults. Total scores range from 0 to 60; higher scores reflect higher anxiety symptoms.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Anxiety Symptoms on the Anxiety Scale for Autism-Adults (ASA-A)
End of Intervention
|
28.86 Score on a Scale
Standard Deviation 10.43
|
|
Change in Anxiety Symptoms on the Anxiety Scale for Autism-Adults (ASA-A)
1 Month Follow-Up
|
26.63 Score on a Scale
Standard Deviation 9.95
|
|
Change in Anxiety Symptoms on the Anxiety Scale for Autism-Adults (ASA-A)
6 Month Follow-Up
|
23.47 Score on a Scale
Standard Deviation 9.73
|
|
Change in Anxiety Symptoms on the Anxiety Scale for Autism-Adults (ASA-A)
Baseline
|
33.79 Score on a Scale
Standard Deviation 8.40
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The University of California Los Angeles (UCLA) 3-Item Loneliness Scale is a self-report measure for symptoms of loneliness. Scores range from 3 to 9; higher scores reflect higher levels of loneliness.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Loneliness Symptoms on the University of California Los Angeles (UCLA) 3-Item Loneliness Scale
Baseline
|
7.68 Score on a Scale
Standard Deviation 1.61
|
|
Change in Loneliness Symptoms on the University of California Los Angeles (UCLA) 3-Item Loneliness Scale
End of Intervention
|
7.24 Score on a Scale
Standard Deviation 1.97
|
|
Change in Loneliness Symptoms on the University of California Los Angeles (UCLA) 3-Item Loneliness Scale
1 Month Follow-Up
|
7.16 Score on a Scale
Standard Deviation 1.46
|
|
Change in Loneliness Symptoms on the University of California Los Angeles (UCLA) 3-Item Loneliness Scale
6 Month Follow-Up
|
6.65 Score on a Scale
Standard Deviation 1.84
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Brief Adjustment Scale (BASE-6) is a brief self-report symptom monitoring measure for general psychological adjustment. Scores from from 6 to 42; higher scores reflect greater psychological adjustment concerns.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Psychological Adjustment Concerns on the Brief Adjustment Scale (BASE-6)
Baseline
|
26.93 Score on a Scale
Standard Deviation 5.44
|
|
Change in Psychological Adjustment Concerns on the Brief Adjustment Scale (BASE-6)
End of Intervention
|
22.70 Score on a Scale
Standard Deviation 9.75
|
|
Change in Psychological Adjustment Concerns on the Brief Adjustment Scale (BASE-6)
1 Month Follow-Up
|
20.95 Score on a Scale
Standard Deviation 7.47
|
|
Change in Psychological Adjustment Concerns on the Brief Adjustment Scale (BASE-6)
6 Month Follow-Up
|
20.06 Score on a Scale
Standard Deviation 9.25
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Brief Experiential Avoidance Questionnaire is a self-report measure of experiential avoidance. Scores range from 15 to 90; higher scores reflect greater levels of experiential avoidance.
Outcome measures
| Measure |
Written Exposure Therapy
n=27 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Experiential Avoidance Symptoms on the Brief Experiential Avoidance Questionnaire
Baseline
|
57.59 Score on a Scale
Standard Deviation 10.36
|
|
Change in Experiential Avoidance Symptoms on the Brief Experiential Avoidance Questionnaire
End of Intervention
|
51.10 Score on a Scale
Standard Deviation 12.05
|
|
Change in Experiential Avoidance Symptoms on the Brief Experiential Avoidance Questionnaire
1 Month Follow-Up
|
49.79 Score on a Scale
Standard Deviation 12.37
|
|
Change in Experiential Avoidance Symptoms on the Brief Experiential Avoidance Questionnaire
6 Month Follow-Up
|
47.82 Score on a Scale
Standard Deviation 12.01
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Difficulties in Emotion Regulation Scale (DERS-16) is a self-report measure of emotion regulation difficulties. Scores range from 16 to 80; higher scores reflect greater emotion regulation difficulties.
Outcome measures
| Measure |
Written Exposure Therapy
n=27 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Emotion Regulation Difficulties on the Difficulties in Emotion Regulation Scale (DERS-16)
Baseline
|
53.52 Score on a Scale
Standard Deviation 11.28
|
|
Change in Emotion Regulation Difficulties on the Difficulties in Emotion Regulation Scale (DERS-16)
End of Intervention
|
47.80 Score on a Scale
Standard Deviation 14.29
|
|
Change in Emotion Regulation Difficulties on the Difficulties in Emotion Regulation Scale (DERS-16)
1 Month Follow-Up
|
46.74 Score on a Scale
Standard Deviation 13.47
|
|
Change in Emotion Regulation Difficulties on the Difficulties in Emotion Regulation Scale (DERS-16)
6 Month Follow-Up
|
45.41 Score on a Scale
Standard Deviation 12.81
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Ultra Brief Self-Stigma of Seeking Help (SSOSH-3) Scale is a self-report measure of stigma towards seeking psychological support. Scores range from 3 to 15; higher scores reflect greater stigma.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Stigma Towards Help-seeking on the Ultra-Brief Self-Stigma of Seeking Help (SSOSH-3) Scale
Baseline
|
5.25 Score on a Scale
Standard Deviation 3.13
|
|
Change in Stigma Towards Help-seeking on the Ultra-Brief Self-Stigma of Seeking Help (SSOSH-3) Scale
End of Intervention
|
4.50 Score on a Scale
Standard Deviation 2.70
|
|
Change in Stigma Towards Help-seeking on the Ultra-Brief Self-Stigma of Seeking Help (SSOSH-3) Scale
1 Month Follow-Up
|
4.63 Score on a Scale
Standard Deviation 2.45
|
|
Change in Stigma Towards Help-seeking on the Ultra-Brief Self-Stigma of Seeking Help (SSOSH-3) Scale
6 Month Follow-Up
|
4.47 Score on a Scale
Standard Deviation 1.94
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Camouflaging Autistic Traits Questionnaire (CATQ) is a self-report measure of masking autistic traits. Scores range from 25 to 175; greater scores reflect a higher level of camouflaging.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Camouflaging on the Camouflaging Autistic Traits Questionnaire (CATQ)
Baseline
|
137.07 Score on a Scale
Standard Deviation 19.46
|
|
Change in Camouflaging on the Camouflaging Autistic Traits Questionnaire (CATQ)
End of Intervention
|
128.33 Score on a Scale
Standard Deviation 25.19
|
|
Change in Camouflaging on the Camouflaging Autistic Traits Questionnaire (CATQ)
1 Month Follow-Up
|
128.44 Score on a Scale
Standard Deviation 22.59
|
|
Change in Camouflaging on the Camouflaging Autistic Traits Questionnaire (CATQ)
6 Month Follow-Up
|
126.24 Score on a Scale
Standard Deviation 18.05
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Pittsburgh Sleep Quality Index (PSQI) is a self-report measure of sleep difficulties. Scores range from 0 to 21; higher scores reflect greater sleep difficulties.
Outcome measures
| Measure |
Written Exposure Therapy
n=22 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Sleep Difficulties on the Pittsburgh Sleep Quality Index (PSQI)
Baseline
|
10.64 Score on a Scale
Standard Deviation 3.87
|
|
Change in Sleep Difficulties on the Pittsburgh Sleep Quality Index (PSQI)
End of Intervention
|
9.42 Score on a Scale
Standard Deviation 2.81
|
|
Change in Sleep Difficulties on the Pittsburgh Sleep Quality Index (PSQI)
1 Month Follow-Up
|
9.86 Score on a Scale
Standard Deviation 4.20
|
|
Change in Sleep Difficulties on the Pittsburgh Sleep Quality Index (PSQI)
6 Month Follow-Up
|
10.14 Score on a Scale
Standard Deviation 4.04
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form Scale is a self-report measure of pain intensity. Total scores range from 3 to 15; higher scores reflect more intense pain.
Outcome measures
| Measure |
Written Exposure Therapy
n=27 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Pain Intensity on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form Scale.
Baseline
|
11.15 Score on a Scale
Standard Deviation 4.36
|
|
Change in Pain Intensity on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form Scale.
End of Intervention
|
10.55 Score on a Scale
Standard Deviation 4.93
|
|
Change in Pain Intensity on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form Scale.
1 Month Follow-Up
|
9.89 Score on a Scale
Standard Deviation 5.51
|
|
Change in Pain Intensity on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Intensity Short Form Scale.
6 Month Follow-Up
|
10.20 Score on a Scale
Standard Deviation 5.02
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form Scale is a self-report measure of pain interference. Total scores range from 8 to 40; higher scores reflect a greater level of pain interference.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Pain Interference on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form Scale.
Baseline
|
19.61 Score on a Scale
Standard Deviation 9.41
|
|
Change in Pain Interference on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form Scale.
End of Intervention
|
18.85 Score on a Scale
Standard Deviation 9.88
|
|
Change in Pain Interference on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form Scale.
1 Month Follow-Up
|
18.05 Score on a Scale
Standard Deviation 10.39
|
|
Change in Pain Interference on the Patient-Reported Outcome Measurement Information System (PROMIS) Pain Interference Short Form Scale.
6 Month Follow-Up
|
16.53 Score on a Scale
Standard Deviation 8.55
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
Participants Fitbit measurements of number of steps (average past week daily steps) will be assessed via their Fitbit device.
Outcome measures
| Measure |
Written Exposure Therapy
n=14 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Physical Activity as Assessed on Fitbit.
Baseline
|
6967.60 Number of steps
Standard Deviation 3689.05
|
|
Change in Physical Activity as Assessed on Fitbit.
End of Intervention
|
6846.04 Number of steps
Standard Deviation 4339.02
|
|
Change in Physical Activity as Assessed on Fitbit.
1 Month Follow-Up
|
6381.08 Number of steps
Standard Deviation 3244.95
|
|
Change in Physical Activity as Assessed on Fitbit.
6 Month Follow-Up
|
4658.71 Number of steps
Standard Deviation 1549.74
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
Participants Fitbit measurements of sleep duration in hours (past weekly nightly average in hours) will be assessed via their Fitbit device. A higher sleep duration indicates greater numbers slept.
Outcome measures
| Measure |
Written Exposure Therapy
n=14 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Sleep Duration as Assessed on Fitbit.
Baseline
|
7.13 Hours
Standard Deviation 1.18
|
|
Change in Sleep Duration as Assessed on Fitbit.
End of Intervention
|
7.13 Hours
Standard Deviation 1.89
|
|
Change in Sleep Duration as Assessed on Fitbit.
1 Month Follow-Up
|
7.02 Hours
Standard Deviation 1.05
|
|
Change in Sleep Duration as Assessed on Fitbit.
6 Month Follow-Up
|
7.05 Hours
Standard Deviation 1.20
|
SECONDARY outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
Participants Fitbit measurements of resting heart rate (past week daily average) will be assessed via their Fitbit device.
Outcome measures
| Measure |
Written Exposure Therapy
n=14 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Resting Heart Rate as Assessed on Fitbit.
Baseline
|
68.17 Beats per minute/day
Standard Deviation 7.69
|
|
Change in Resting Heart Rate as Assessed on Fitbit.
End of Intervention
|
68.25 Beats per minute/day
Standard Deviation 7.24
|
|
Change in Resting Heart Rate as Assessed on Fitbit.
1 Month Follow-Up
|
68.35 Beats per minute/day
Standard Deviation 8.35
|
|
Change in Resting Heart Rate as Assessed on Fitbit.
6 Month Follow-Up
|
70.53 Beats per minute/day
Standard Deviation 8.21
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Autism Spectrum Quality of Life Scale is a self-report measure of quality of life relating to autism. Total scores range from 9 to 45, and higher scores reflect greater quality of life.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Autistic Quality of Life on the Autism Spectrum Quality of Life Scale.
Baseline
|
27.79 Score on a Scale
Standard Deviation 5.01
|
|
Change in Autistic Quality of Life on the Autism Spectrum Quality of Life Scale.
End of Intervention
|
28.57 Score on a Scale
Standard Deviation 5.52
|
|
Change in Autistic Quality of Life on the Autism Spectrum Quality of Life Scale.
1 Month Follow-Up
|
28 Score on a Scale
Standard Deviation 4.88
|
|
Change in Autistic Quality of Life on the Autism Spectrum Quality of Life Scale.
6 Month Follow-Up
|
28.94 Score on a Scale
Standard Deviation 3.67
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The World Health Organization Quality of Life Scale (WHO QOL) is a 26-item self-report questionnaire of quality of life. Summed total scores range from 26 to 130, and higher scores reflect greater quality of life.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Overall Quality of Life on the World Health Organization Quality of Life Scale
Baseline
|
77.07 Score on a Scale
Standard Deviation 16.02
|
|
Change in Overall Quality of Life on the World Health Organization Quality of Life Scale
End of Intervention
|
78.24 Score on a Scale
Standard Deviation 16.43
|
|
Change in Overall Quality of Life on the World Health Organization Quality of Life Scale
1 Month Follow-Up
|
80.89 Score on a Scale
Standard Deviation 16.22
|
|
Change in Overall Quality of Life on the World Health Organization Quality of Life Scale
6 Month Follow-Up
|
80.41 Score on a Scale
Standard Deviation 16.81
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Change across baseline to follow-up (e.g., Baseline, End of Intervention [approximately 1 week after intervention completion], 1 month after intervention completion, and 6 months after intervention completion)Population: The number of participants reported here may differ from the numbers reported in the Participant Flow because some participants did not complete all measures at all time points.
The Autism Spectrum Identity Scale (ASIS) is a 22-item self-report of autistic identity. Total scores range from 22 to 110, and higher scores reflect a more positive Autistic identity.
Outcome measures
| Measure |
Written Exposure Therapy
n=28 Participants
Behavioral therapy: Written Exposure Therapy via telehealth
|
|---|---|
|
Change in Positive Autistic Identity on the Autism Spectrum Identity Scale (ASIS)
Baseline
|
61.82 Score on a Scale
Standard Deviation 9.79
|
|
Change in Positive Autistic Identity on the Autism Spectrum Identity Scale (ASIS)
End of Intervention
|
61.75 Score on a Scale
Standard Deviation 10.03
|
|
Change in Positive Autistic Identity on the Autism Spectrum Identity Scale (ASIS)
1 Month Follow-Up
|
61.94 Score on a Scale
Standard Deviation 12.58
|
|
Change in Positive Autistic Identity on the Autism Spectrum Identity Scale (ASIS)
6 Month Follow-Up
|
58.00 Score on a Scale
Standard Deviation 11.95
|
Adverse Events
Written Exposure Therapy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place